Plasma and cellular pharmacokinetics of mitoxantrone in high-dose chemotherapeutic regimen for refractory lymphomas.

Canal, P; Attal, M; Chatelut, E; Guichard, S; Huguet, F; Muller, C; Schlaifer, D; Laurent, G; Houin, G; Bugat, R

Canal, P; Attal, M; Chatelut, E; Guichard, S; Huguet, F; Muller, C; Schlaifer, D; Laurent, G; Houin, G; Bugat, R.

Affiliation

Canal P; Groupe de Pharmacologie Clinique et Expérimentale des Médicaments Anticancéreux, Centre Claudius Regaud, Toulouse, France.

Cancer Res ; 53(20): 4850-4, 1993 Oct 15.

Article in En | MEDLINE | ID: mdl-8402672

Subject(s)

Lymphoma/drug therapy; Mitoxantrone/pharmacokinetics; Mitoxantrone/toxicity; Adult; Dose-Response Relationship, Drug; Hodgkin Disease/drug therapy; Humans; Lymphoma/blood; Lymphoma/pathology; Lymphoma, Non-Hodgkin/drug therapy; Metabolic Clearance Rate; Middle Aged; Mitoxantrone/blood

Search on Google

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Mitoxantrone / Lymphoma Limits: Adult / Humans / Middle aged Language: En Journal: Cancer Res Year: 1993 Type: Article Affiliation country: France

Search on Google

XML

PubMed Links